None listed
Conditions
Interventions
Intervention1: FSFW0121: Oral administration of FSFW0121 thrice a day for 56 days
Control Intervention1: Placebo: Oral administration of Placebo thrice a day for 56 days
Sponsors
Akay Natural Ingredients Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Body Mass Index higher than 25 up to 35 kg/m2 2.currently not involved in any weight loss program or weight loss treatment 3.No history of allergic to herbal products 4. Non Smoker 5. Willing to provide written informed consent
Exclusion criteria
Exclusion criteria: 1.Subjects having symptoms of viral infection, including COVID-19 infection 2.Subjects with Clinically significant comorbidity 3.History of clinically significant illness or any other medical disorder that may interfere with subject treatment, assessment or compliance with the protocol. 4.Subjects currently on any other dietary supplementation 5.Visually or mentally handicapped 6.Any other condition that in the view of the investigator renders the subject inappropriate for enrolment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in appetite score and anthropometric parametersTimepoint: Day 0, Day 28, Day 56 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Appetite and Obesity BiomarkersTimepoint: Day 0, Day 28, Day 56;Change in Biochemical and Hematological parametersTimepoint: Day 0, Day 28, Day 56 | — |
Countries
India
Contacts
Public ContactJestin V Thomas
Leads Clinical Research and Bio Services Pvt. Ltd
Outcome results
None listed